Dalian BIO-CHEM Company Limited
603360.SS · SHH
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | CN¥17,107,948 | CN¥11,271,351 | CN¥10,865,041 | CN¥8,019,268 |
| - Cash | CN¥651,627 | CN¥541,014 | CN¥845,334 | CN¥668,244 |
| + Debt | CN¥1,120,257 | CN¥888,813 | CN¥999,199 | CN¥532,543 |
| Enterprise Value | CN¥17,576,578 | CN¥11,619,150 | CN¥11,018,905 | CN¥7,883,567 |
| Revenue | CN¥307,191 | CN¥300,237 | CN¥448,322 | CN¥416,071 |
| % Growth | 2.3% | -33% | 7.8% | – |
| Gross Profit | CN¥106,501 | CN¥104,893 | CN¥141,163 | CN¥160,386 |
| % Margin | 34.7% | 34.9% | 31.5% | 38.5% |
| EBITDA | CN¥46,350 | CN¥71,659 | CN¥90,082 | CN¥138,170 |
| % Margin | 15.1% | 23.9% | 20.1% | 33.2% |
| Net Income | CN¥33,208 | CN¥41,627 | CN¥50,162 | CN¥91,034 |
| % Margin | 10.8% | 13.9% | 11.2% | 21.9% |
| EPS Diluted | 0.047 | 0.083 | 0.1 | 0.18 |
| % Growth | -42.9% | -17% | -44.4% | – |
| Operating Cash Flow | CN¥201,467 | CN¥53,968 | -CN¥59,596 | CN¥0 |
| Capital Expenditures | -CN¥10,851 | -CN¥3,171 | -CN¥19,009 | -CN¥26,281 |
| Free Cash Flow | CN¥190,616 | CN¥50,796 | -CN¥78,654 | -CN¥99,139 |